The association between serum tacrolimus concentrations and BK viruria in kidney transplant recipients
- PMID: 39843551
- PMCID: PMC11754913
- DOI: 10.1038/s41598-025-86465-2
The association between serum tacrolimus concentrations and BK viruria in kidney transplant recipients
Abstract
The objective of this study was to examine the association between serum tacrolimus trough levels and the detection of BK viruria in kidney transplant recipients. We conducted a retrospective study and included kidney transplant recipients who underwent BK viruria screening during 2018-2021. Serum tacrolimus trough levels, urine BK viral load, and potential risk factors were collected. Statistical analysis was performed to identify the association between the serum tacrolimus trough levels and the detection of BK virus in urine (defined as positive BK viruria), as well as to determine the cumulative incidence and risk factors for BK viruria. Out of 243 recipients, 76 had positive BK viruria. The average serum tacrolimus trough level was significantly higher among the positive BK viruria group compared to the BK viruria-negative group. High HLA mismatch was identified as a risk factor for BK viruria. Approximately half of the recipients with average serum tacrolimus trough levels exceeding 10 ng/mL would develop BK viruria early. This study found an association between the average serum tacrolimus trough level and the detection of BK viruria. High HLA mismatch and an average serum tacrolimus trough level exceeding 10 ng/mL should be regarded as a risk for BK viruria.
Keywords: BK viruria; BK virus nephropathy; Risk factors; Tacrolimus; Therapeutic drug monitoring.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests. Ethical approval: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Research Ethics Committee of the Faculty of Medicine, Chiang Mai University (No.146/2021). Interests to declare: The authors have no relevant financial or non-financial interests to disclose. Informed consent: Patient consent was waived due to the retrospective nature of this study. The Research Ethics Committee of the Faculty of Medicine, Chiang Mai University, granted a waiver of informed consent.
Figures


Similar articles
-
BK and JC polyomavirus infections in Tunisian renal transplant recipients.J Med Virol. 2015 Oct;87(10):1788-95. doi: 10.1002/jmv.24234. Epub 2015 May 7. J Med Virol. 2015. PMID: 25952258
-
BK virus replication in renal transplant recipients: Analysis of potential risk factors may contribute in reactivation.J Clin Virol. 2017 Nov;96:7-11. doi: 10.1016/j.jcv.2017.09.004. Epub 2017 Sep 8. J Clin Virol. 2017. PMID: 28915452
-
Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation.Transpl Infect Dis. 2018 Aug;20(4):e12917. doi: 10.1111/tid.12917. Epub 2018 Jun 11. Transpl Infect Dis. 2018. PMID: 29800505
-
Evaluation of new-onset BK viruria in post-renal transplant recipients by quantitative PCR.Transpl Immunol. 2024 Dec;87:102136. doi: 10.1016/j.trim.2024.102136. Epub 2024 Oct 4. Transpl Immunol. 2024. PMID: 39370011
-
BK virus-associated viruria and viremia in a patient with lymphangioleiomyomatosis after lung re-transplantation: A case report and review of the literature on BK virus infection post-lung transplantation.J Infect Chemother. 2019 Oct;25(10):820-824. doi: 10.1016/j.jiac.2019.04.002. Epub 2019 Apr 23. J Infect Chemother. 2019. PMID: 31027885 Review.
References
-
- Jamboti, J. S. BK virus nephropathy in renal transplant recipients. Nephrol. (Carlton). 21 (8), 647–654 (2016). - PubMed
-
- Leung, A. Y., Chan, M., Tang, S. C., Liang, R. & Kwong, Y. L. Real-time quantitative analysis of polyoma BK viremia and viruria in renal allograft recipients. J. Virol. Methods. 103 (1), 51–56 (2002). - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials